Newron Pharmaceuticals S.p.A. (NWRN.SW) SIX

14.22

+0.12(+0.85%)

Updated at October 21 01:48PM

Currency In CHF

Valuation

Market Cap176.72M
Enterprise Value220.26M
P/E Ratio11.92
PEG Ratio0.2
Price/Sales Ratio5.04
Price/Book Ratio190.91
Enterprise/Revenue5.48
Enterprise/EBITDA9.38

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.42
Operating Margin0.59

Management Effectiveness

Return On Assets0.41
Return On Equity16.66

Income Statement

Revenue51.39M
Revenue/Share3
Gross Profit51.39M
EBITDA25.94M
Net Income15.84M
Diluted EPS0.85

Balance Sheet

Total Cash43.2M
Total Cash/Share2.16
Total Debt52.57M
Total Debt/Equity33.23
Current Ratio1.51
Book Value Per Share0.08

Price History

52-Week Change55.8
52-Week High16
52-Week Low5.2
Moving Average 50 Days10.38
Moving Average 200 Days8.59

Statistics

Average Volume117,625
Shares Outstanding19.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A